Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Healthcare providers need better education and policies to serve transgender individuals effectively.